Sign Out
Each mL contains 50 mg of durvalumab.
Each vial of 2.4 mL contains 120 mg of durvalumab.
Each vial of 10 mL contains 500 mg of durvalumab.
Durvalumab (IMFINZI) is a human immunoglobulin (IgG1κ) monoclonal antibody.
Injection (US) or concentrate for solution for infusion (EU); 50 mg/mL in single-dose vial for intravenous administration.
Sterile, preservative-free, clear to opalescent, colourless to slightly yellow solution, free from visible particles.
Excipients/Inactive Ingredients: L-histidine, L-histidine hydrochloride monohydrate, α,α-Trehalose dihydrate, Polysorbate 80, Water for Injection.
Continue with Google